As broader approval for GLP-1 weight loss drugs spurs higher demand, it's also causing employer drug spending to spike.
Source: CNBC
30. April 2025 12:00
As broader approval for GLP-1 weight loss drugs spurs higher demand, it's also causing employer drug spending to spike.
Source: CNBC